DrugPatentWatch Database Preview
SEIZALAM Drug Profile
When do Seizalam patents expire, and what generic alternatives are available?
Seizalam is a drug marketed by Meridian Medcl Techn and is included in one NDA.
The generic ingredient in SEIZALAM is midazolam hydrochloride. There are nine drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the midazolam hydrochloride profile page.
Summary for SEIZALAM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | SEIZALAM at DailyMed |
Medical Subject Heading (MeSH) Categories for SEIZALAM
US Patents and Regulatory Information for SEIZALAM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Meridian Medcl Techn | SEIZALAM | midazolam hydrochloride | SOLUTION;INTRAMUSCULAR | 209566-001 | Sep 14, 2018 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
